Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib 由 Coombes, RC, Howell, S, Lord, SR, Kenny, L, Mansi, J, Mitri, Z, Palmieri, C, Chap, LI, Richards, P, Gradishar, W, Sardesai, S, Melear, J, O’Shaughnessy, J, Ward, P, Chalasani, P, Arkenau, T, Baird, RD, Jeselsohn, R, Ali, S, Clack, G, Bahl, A, McIntosh, S, Krebs, MG